Ligand · SL8
SL8 · ~{N}-[3-[(3~{R},6~{R})-5-azanyl-3,6-dimethyl-6-(trifluoromethyl)-2~{H}-1,4-oxazin-3-yl]phenyl]-5-bromanyl-pyridine-2-carboxamide
SL8, ~{N}-[3-[(3~{R},6~{R})-5-azanyl-3,6-dimethyl-6-(trifluoromethyl)-2~{H}-1,4-oxazin-3-yl]phenyl]-5-bromanyl-pyridine-2-carboxamide (C19 H18 Br F3 N4 O2, 471.3 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB…
- Component
- SL8
- Formula
- C19 H18 Br F3 N4 O2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
SL8 in 2 structures; the first of them:
- 7B1P · Crystal Structure of Human BACE-1 in Complex with Compound 38a (NB-854) · SL8 A501 · binds GLY11, GLN12, GLY13, TYR14, LEU30, ASP32, GLY34, SER35 and 11 more
- 7B1P · Crystal structure of human bace-1 in complex with compound 38A (nb- 854) · SL8 A501 · binds GLY11, GLN12, GLY13, TYR14, LEU30, ASP32, GLY34, SER35 and 11 more
Residues it binds most
GLY 2, ASP 2, ILE 2, SER 2, THR 2, TYR 2, ALA 2, GLN 2, LEU 2, PHE 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.